Skip to content

Clinical trials

Phase 1 Stroke trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Stroke Phase: Phase 1 Country / region: China Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20124
20141
20171
20191
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status5
Completed3
Recruiting2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Capital Medical University3
Qilu Hospital of Shandong University2
Lifetech Scientific (Shenzhen) Co., Ltd.1
Peking Union Medical College Hospital1
Southern Medical University, China1
Suzhou Yabao Pharmaceutical R&D Co., Ltd.1
Wenzhou Medical University1
Zhejiang Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stroke11
Ischemic Stroke4
Paresis2
Atrial Fibrillation1
Bronchiolitis Obliterans Syndrome1
Cerebral Hemorrhage1
Cerebrovascular Disorders1
Coronary Stenosis1
Thrombosis1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.